Na Češkem, v Estoniji, Latviji, Litvi, na Madžarskem, Poljskem, v Sloveniji ali na Slovaškem se lahko imetnik patenta ali dodatnega varstvenega certifikata za farmacevtski proizvod, ki je prijavljen v državi članici, ker taka zaščita ni mogla biti pridobljena v eni izmed zgoraj omenjenih držav, ali njegov upravičenec, sklicuje na pravice, podeljene s tem patentom ali dodatnim varstvenim certifikatom, da bi prepreči uvoz in trženje tega proizvoda v državah članicah oziroma državah, kjer ta proizvod uživa patentno varstvo ali varstvo z dodatnim certifikatom, tudi če je proizvod prvič dal na trg v novi državi članici imetnik, ali se je to zgodilo z njegovim soglasjem.
With regard to the Czech Republic, Estonia, Latvia, Lithuania, Hungary, Poland, Slovenia or Slovakia, the holder, or his beneficiary, of a patent or supplementary protection certificate for a pharmaceutical product filed in a Member State at a time when such protection could not be obtained in one of the abovementioned new Member States for that product, may rely on the rights granted by that patent or supplementary protection certificate in order to prevent the import and marketing of that product in the Member State or States where the product in question enjoys patent protection or supplementary protection, even if the product was put on the market in that new Member State for the first time by him or with his consent.